Eileen Baildam
Overview
Explore the profile of Eileen Baildam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1265
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kearsley-Fleet L, Sampath S, McCann L, Baildam E, Beresford M, Davies R, et al.
Rheumatology (Oxford)
. 2018 Oct;
58(2):331-335.
PMID: 30358861
Objectives: Rituximab (RTX) may be a treatment option for children and young people with JIA, although it is not licensed for this indication. The aim of this study was to...
12.
Kearsley-Fleet L, Beresford M, Davies R, De Cock D, Baildam E, Foster H, et al.
Rheumatology (Oxford)
. 2018 Aug;
58(1):94-102.
PMID: 30137641
Objectives: To investigate real-world short-term outcomes among patients with systemic JIA starting tocilizumab or anakinra. Methods: This analysis included all systemic JIA patients within the UK Biologics for Children with...
13.
Hanns L, Cordingley L, Galloway J, Norton S, Carvalho L, Christie D, et al.
Rheumatology (Oxford)
. 2018 Apr;
57(8):1381-1389.
PMID: 29697850
Objectives: To determine if depressive symptoms assessed near diagnosis associate with future measures of pain, disability and disease for adolescent patients diagnosed with JIA. Methods: Data were analysed from JIA...
14.
Shoop-Worrall S, Verstappen S, McDonagh J, Baildam E, Chieng A, Davidson J, et al.
Arthritis Rheumatol
. 2018 Apr;
70(9):1519-1529.
PMID: 29648683
Objective: Potential targets for treat-to-target strategies in juvenile idiopathic arthritis are minimal disease activity (MDA) and clinically inactive disease (CID). We undertook this study to compare short- and long-term outcomes...
15.
Dayal D, Pepper O, Ramakrishnan R, Baildam E, Dharmaraj P, Cleary G, et al.
Int J Endocrinol Metab
. 2018 Jan;
15(4):e57199.
PMID: 29344035
Introduction: Sarcoidosis is a multisystemic granulomatous disease with diverse and often non-specific symptoms during childhood. The clinical manifestations sometimes include endocrinopathies related to sarcoid infiltration of various endocrine organs, but...
16.
Lythgoe H, Baildam E, Beresford M, Cleary G, McCann L, Pain C
Rheumatology (Oxford)
. 2017 Oct;
57(2):398-401.
PMID: 29077971
No abstract available.
17.
Shoop-Worrall S, Verstappen S, Baildam E, Chieng A, Davidson J, Foster H, et al.
Ann Rheum Dis
. 2017 Apr;
76(8):1381-1388.
PMID: 28389553
Objectives: Many criteria for clinically inactive disease (CID) and minimal disease activity (MDA) have been proposed for juvenile idiopathic arthritis (JIA). It is not known to what degree each of...
18.
Davies R, Southwood T, Kearsley-Fleet L, Lunt M, Baildam E, Beresford M, et al.
Arch Dis Child
. 2016 Nov;
102(2):206-207.
PMID: 27799155
No abstract available.
19.
Frid P, Nordal E, Bovis F, Giancane G, Larheim T, Rygg M, et al.
Arthritis Care Res (Hoboken)
. 2016 Aug;
69(5):677-686.
PMID: 27564918
Objective: To evaluate the demographic, disease activity, disability, and health-related quality of life (HRQOL) differences between children with juvenile idiopathic arthritis (JIA) and their healthy peers, and between children with...
20.
Bellutti Enders F, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman B, et al.
Ann Rheum Dis
. 2016 Aug;
76(2):329-340.
PMID: 27515057
Background: In 2012, a European initiative called Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic and management regimens in Europe...